This company has been acquired
PetIQ Past Earnings Performance
Past criteria checks 2/6
PetIQ has been growing earnings at an average annual rate of 15.7%, while the Healthcare industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 10.4% per year. PetIQ's return on equity is 5.3%, and it has net margins of 1.2%.
Key information
15.7%
Earnings growth rate
18.4%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 10.4% |
| Return on equity | 5.3% |
| Net Margin | 1.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?
Aug 14
PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2
Aug 09PetIQ: Product Margin Gains Offset By Higher Marketing Spend
Jul 09White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative
Apr 20PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly
Apr 13PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate
Feb 06Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist
Sep 15PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company
Aug 16PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet
Aug 10PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher
Jun 14PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital
Feb 11PetIQ gains 1.84 % on $30M stock repurchase program
Sep 06PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky
Aug 23Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital
Jul 27Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?
May 06There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital
Apr 02The Prognosis For PetIQ
Feb 12PetIQ: Economies Of Scale Will Kick In Eventually
Jan 03Revenue & Expenses Breakdown
How PetIQ makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,134 | 13 | 202 | 1 |
| 31 Mar 24 | 1,120 | 7 | 197 | 1 |
| 31 Dec 23 | 1,102 | 2 | 190 | 1 |
| 30 Sep 23 | 1,066 | 13 | 186 | 2 |
| 30 Jun 23 | 999 | -37 | 177 | 2 |
| 31 Mar 23 | 936 | -42 | 172 | 2 |
| 31 Dec 22 | 922 | -48 | 174 | 2 |
| 30 Sep 22 | 934 | -55 | 173 | 8 |
| 30 Jun 22 | 935 | -14 | 170 | 8 |
| 31 Mar 22 | 954 | -15 | 164 | 8 |
| 31 Dec 21 | 933 | -16 | 158 | 8 |
| 30 Sep 21 | 900 | -11 | 136 | 0 |
| 30 Jun 21 | 852 | -73 | 138 | 0 |
| 31 Mar 21 | 848 | -79 | 122 | 1 |
| 31 Dec 20 | 780 | -83 | 116 | 2 |
| 30 Sep 20 | 770 | -85 | 121 | 3 |
| 30 Jun 20 | 794 | -20 | 102 | 3 |
| 31 Mar 20 | 748 | -15 | 95 | 2 |
| 31 Dec 19 | 709 | -11 | 91 | 1 |
| 30 Sep 19 | 666 | -4 | 84 | 0 |
| 30 Jun 19 | 611 | 4 | 75 | 0 |
| 31 Mar 19 | 562 | 3 | 69 | 0 |
| 31 Dec 18 | 529 | -1 | 67 | 0 |
| 30 Sep 18 | 470 | -1 | 60 | 0 |
| 30 Jun 18 | 399 | -3 | 53 | 0 |
| 31 Mar 18 | 315 | -6 | 49 | 0 |
| 31 Dec 17 | 267 | -3 | 37 | 1 |
| 30 Sep 17 | 260 | 0 | 34 | 0 |
| 30 Jun 17 | 241 | 0 | 32 | 0 |
| 31 Mar 17 | 215 | -2 | 29 | 0 |
| 31 Dec 16 | 200 | 0 | 28 | 0 |
| 31 Mar 16 | 202 | -5 | 33 | 0 |
| 31 Dec 15 | 206 | 0 | 35 | 0 |
| 31 Dec 14 | 161 | -11 | 29 | 1 |
Quality Earnings: PETQ has a large one-off loss of $19.8M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: PETQ became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PETQ has become profitable over the past 5 years, growing earnings by 15.7% per year.
Accelerating Growth: PETQ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PETQ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (10.1%).
Return on Equity
High ROE: PETQ's Return on Equity (5.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/24 07:51 |
| End of Day Share Price | 2024/10/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PetIQ, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Lawrence | Benchmark Company |
| David Westenberg | CL King & Associates, Inc. |
| David Westenberg | Guggenheim Securities, LLC |